Vivo Bio Tech Limited (BOM:511509)
India · Delayed Price · Currency is INR 24.03
0.00 (0.00%)
At close: Jun 19, 2026
Vivo Bio Tech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 14.36 | 12.81 | 13.9 | 13.75 | 17.14 |
Cash & Short-Term Investments | 14.36 | 12.81 | 13.9 | 13.75 | 17.14 |
Cash Growth | 12.10% | -7.84% | 1.08% | -19.77% | 47.03% |
Accounts Receivable | 117.47 | 112.51 | 117.95 | 123.8 | 120.24 |
Other Receivables | 10.1 | 7.57 | 10.58 | 32.28 | 8.89 |
Receivables | 188.29 | 321.16 | 363.21 | 216.5 | 136.25 |
Inventory | 81.52 | 77.91 | 87.74 | 79.73 | 98.12 |
Other Current Assets | - | 7.5 | 7.48 | 7.94 | 8.81 |
Total Current Assets | 284.16 | 419.37 | 472.32 | 317.91 | 260.32 |
Property, Plant & Equipment | 766.07 | 772.24 | 814.65 | 799.62 | 824.13 |
Long-Term Investments | 219.1 | - | - | - | - |
Other Intangible Assets | 512.27 | 238.57 | 81.21 | 108.06 | 136.24 |
Long-Term Deferred Charges | 2.72 | 2.14 | 3.16 | 4.73 | 4.17 |
Other Long-Term Assets | -0 | - | 0 | 0 | - |
Total Assets | 1,784 | 1,432 | 1,371 | 1,230 | 1,225 |
Accounts Payable | 19.62 | 9.81 | 10.6 | 9.42 | 23.16 |
Accrued Expenses | 75 | 49.69 | 37.89 | 36.92 | 27.46 |
Short-Term Debt | - | 113.56 | 226.79 | 115.87 | 109.19 |
Current Portion of Long-Term Debt | 207.71 | 77.32 | 85.98 | 77.17 | 64.41 |
Current Income Taxes Payable | - | 28.03 | 17.89 | 10.31 | 7.59 |
Other Current Liabilities | - | -0 | -0 | 0 | - |
Total Current Liabilities | 302.32 | 278.4 | 379.15 | 249.69 | 231.81 |
Long-Term Debt | 466.09 | 349.37 | 417.87 | 430.92 | 500.78 |
Pension & Post-Retirement Benefits | 9.54 | 7.8 | 6.9 | 6.15 | 5.54 |
Long-Term Deferred Tax Liabilities | 74.78 | 17.7 | 23.42 | 24.85 | 15.44 |
Other Long-Term Liabilities | -0 | 0 | 0 | -0 | 0 |
Total Liabilities | 852.74 | 653.26 | 827.34 | 711.6 | 753.57 |
Common Stock | 221.91 | 171.65 | 149.04 | 149.04 | 142.64 |
Additional Paid-In Capital | - | 216.48 | 149.58 | 149.58 | 128.13 |
Retained Earnings | - | 288.96 | 216.13 | 190.87 | 164.38 |
Comprehensive Income & Other | 709.67 | 101.97 | 29.25 | 29.25 | 36.15 |
Shareholders' Equity | 931.58 | 779.05 | 544 | 518.73 | 471.28 |
Total Liabilities & Equity | 1,784 | 1,432 | 1,371 | 1,230 | 1,225 |
Total Debt | 673.81 | 540.25 | 730.64 | 623.96 | 674.39 |
Net Cash (Debt) | -659.45 | -527.44 | -716.74 | -610.21 | -657.25 |
Net Cash Per Share | -31.64 | -34.49 | -42.97 | -41.16 | -46.40 |
Filing Date Shares Outstanding | 20.49 | 17.16 | 14.9 | 14.9 | 14.26 |
Total Common Shares Outstanding | 20.49 | 17.16 | 14.9 | 14.9 | 14.26 |
Working Capital | -18.16 | 140.97 | 93.17 | 68.22 | 28.51 |
Book Value Per Share | 45.47 | 45.39 | 36.50 | 34.81 | 33.04 |
Tangible Book Value | 419.31 | 540.48 | 462.79 | 410.67 | 335.05 |
Tangible Book Value Per Share | 20.47 | 31.49 | 31.05 | 27.56 | 23.49 |
Land | - | 210.67 | 228.8 | 228.8 | 228.8 |
Buildings | - | 174.89 | 174.89 | 174.89 | 174.89 |
Machinery | - | 753.76 | 751.87 | 747.18 | 717.51 |
Construction In Progress | - | 128.45 | 92.12 | 18.97 | 8.66 |